Axonics (NSDQ:AXNX) announced today that it entered into a strategic alliance with Micro Systems Technologies.
Micro Systems Technologies (MST) manufactures printed circuit board assemblies for the Axonics r-SNM (sacral neuromodulation) system in Lake Oswego, Oregon, according to a news release.
The newly minted strategic alliance expands the relationship between the two as the companies collaborate on the non-rechargeable SNM device that Axonics has developed and plans to bring to market after receiving FDA approval.
“We have been working with MST for over half a decade and we have developed a strong relationship,” Axonics CEO Raymond W. Cohen said in the release. “As Axonics develops new SNM embodiments for the benefit of patients suffering from bladder and bowel dysfunction, working with an experienced, best-in-class contract manufacturer with proven implantable device experience and the ability to rapidly scale is critical to support our long-term growth objectives.”
Axonics’ new non-rechargeable implantable neurostimulator is set to be manufactured on the most advanced printed circuit board assembly line at Micro Systems Engineering, an MST company, offering automation and a paperless traceability system to improve throughput, yields and quality.
“MST is proud to broaden our relationship with Axonics and is committed to continuing to provide the highest quality medical components and automated manufacturing capabilities,” MST president of sales and marketing Christian Roessle said. “Our extensive experience in microelectronics and implantable technology, as well as our specialization in the production of hundreds of thousands of implantable devices, positions MST to provide excellent support to Axonics for years to come.”
